3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Ovarian Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms, Castration-Resistant
2
Fallopian Tube Neoplasms
2
Triple Negative Breast Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Castration-sensitive Prostate Cancer
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
X-Rays
6
Specimen Handling
6
Cyclophosphamide
6
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
4
fludarabine
3
Nuclear Medicine Department, Hospital
3
Doxorubicin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
mifamurtide
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
cabozantinib
2
Methotrexate
2
Mesna
2
Ifosfamide
2
Gemcitabine
2
Cisplatin
2
trastuzumab deruxtecan
1
tazemetostat
1
talazoparib
1
selinexor
1
pembrolizumab
1
pazopanib
1
palbociclib
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
niraparib
×
30 days
×
Clear all
No trials found.